Pharmaceutical Business review

FDA approves Watson Nabumetone Tablets

Nabumetone Tablets are indicated for the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Watson‘s Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) that shows anti-inflammatory, analgesic and antipyretic properties in pharmacologic studies.

The drug contains colloidal silicon dioxide, D&C yellow #10 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium lauryl sulfate, sodium starch glycolate and titanium dioxide.

The company expects to make the product available in the market soon.